Skip to content

Shares (Basic) at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
254.1M-1.1%
Gilead Sciences logo
Gilead SciencesGILD
1.2B-0.3%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
96.1M+11.8%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
58.3M+36.5%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
118.5M+14.5%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
418.5M+29.6%

Other financials

Income statement

See full
Operating income-$48.6M+4.0%
Net income-$47.2M+4.4%
EPS (diluted)-$0.17+19.0%

Balance sheet

See full
Cash & equivalents$83.8M-12.8%
Total debt$75.3M-17.5%
Total equity$119.2M-43.0%
Total assets$373.6M-16.1%

Cash flow

See full
Operating cash flow-$37.4M+23.2%
CapEx$288.0K+112%
Free cash flow-$37.7M+22.8%

Valuation

See full
Market cap$907.23M+54.1%
Enterprise value$898.76M+53.9%

Returns & leverage

See full
Return on equity-147.4%-2,468pp
Debt / equity0.6×+0.2×
Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sana Biotechnology's shares (basic)?
Sana Biotechnology (SANA) reported shares (basic) of 276.9M in Q1 2026.
How has Sana Biotechnology's shares (basic) changed year-over-year?
Sana Biotechnology's shares (basic) increased by 16.5% year-over-year, from 237.6M to 276.9M.
What is the long-term trend for Sana Biotechnology's shares (basic)?
Over 3 years (2022 to 2025), Sana Biotechnology's shares (basic) has grown at a 9.6% compound annual growth rate (CAGR), from 751.2M to 989.7M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.